REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 103,945,862
- Total 13F shares
- 92,775,414
- Share change
- -1,334,645
- Total reported value
- $97,325,332,836
- Put/Call ratio
- 123%
- Price per share
- $1051.24
- Number of holders
- 1,377
- Value change
- -$1,389,777,813
- Number of buys
- 653
- Number of sells
- 529
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
10%
|
10,649,474
|
$11,192,916,426 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
8,993,970
|
$9,452,932,289 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.1%
|
8,446,366
|
$8,877,384,199 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
8%
|
8,277,315
|
$8,699,706,984 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,841,127
|
$5,088,169,711 | — | 30 Jun 2024 | |
| Capital World Investors |
13F
|
Company |
4.5%
|
4,638,667
|
$4,875,377,350 | — | 30 Jun 2024 | |
| Capital International Investors |
13F
|
Company |
3%
|
3,134,122
|
$3,294,049,275 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,415,350
|
$2,532,607,916 | — | 30 Jun 2024 | |
| DODGE & COX |
13F
|
Company |
2.2%
|
2,315,686
|
$2,433,855,457 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.9%
|
1,923,102
|
$2,021,237,798 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,341,298
|
$1,409,748,507 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.2%
|
1,216,856
|
$1,278,952,000 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,126,948
|
$1,184,456,156 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
1,061,791
|
$1,115,974,194 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
1%
|
1,064,318
|
$1,090,063,924 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.93%
|
968,104
|
$1,017,506,436 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
966,726
|
$1,016,058,027 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
932,874
|
$980,479,000 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.88%
|
916,420
|
$963,185,387 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.83%
|
864,242
|
$908,344,337 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.82%
|
847,682
|
$890,939,211 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.79%
|
825,832
|
$867,974,917 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.75%
|
783,793
|
$823,792,062 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.67%
|
695,097
|
$730,567,800 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
688,579
|
$723,717,449 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
661,762
|
$695,532,099 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.58%
|
602,325
|
$633,061,644 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
586,562
|
$616,498,432 | — | 30 Jun 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.54%
|
558,787
|
$587,301,901 | — | 30 Jun 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.52%
|
540,293
|
$567,864,152 | — | 30 Jun 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.48%
|
500,274
|
$525,804,000 | — | 30 Jun 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.44%
|
455,800
|
$479,059,681 | — | 30 Jun 2024 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
401,172
|
$421,643,808 | — | 30 Jun 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
376,929
|
$396,163,702 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.36%
|
374,878
|
$394,632,842 | — | 30 Jun 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.35%
|
365,925
|
$384,262,910 | — | 30 Jun 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
362,305
|
$380,793,437 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
351,545
|
$369,484,341 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.34%
|
350,115
|
$367,981,367 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.33%
|
340,566
|
$357,945,083 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.31%
|
319,600
|
$335,909,188 | — | 30 Jun 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.29%
|
297,642
|
$312,830,671 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.28%
|
293,764
|
$308,754,777 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
267,032
|
$280,658,643 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
254,461
|
$267,446,144 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.24%
|
254,415
|
$267,397,797 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.24%
|
246,691
|
$259,279,642 | — | 30 Jun 2024 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.23%
|
241,754
|
$254,090,706 | — | 30 Jun 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.21%
|
213,824
|
$223,813,000 | — | 30 Jun 2024 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.